期刊
IMMUNITY INFLAMMATION AND DISEASE
卷 10, 期 1, 页码 111-116出版社
WILEY
DOI: 10.1002/iid3.541
关键词
HLA; MERS; MERS-CoV; Middle East respiratory syndrome coronavirus
类别
资金
- National Research Foundation of Korea (NRF) - Ministry of Education [2019R1I1A1A01064049]
- National Medical Center of the Republic of Korea [NMC2018-MS-01]
- Korean Health Technology R&D Project of the Ministry for Health & Welfare of the Republic of Korea [HI14C3417]
- National Research Foundation of Korea [2019R1I1A1A01064049] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
The study found that HLA-DQB1*03:02 is significantly associated with moderate/mild cases of MERS-CoV, while other alleles showed no statistical significance. Future treatment strategies may benefit from targeting the HLA gene based on this research on MERS-CoV.
Introduction: Middle East Respiratory Syndrome (MERS) caused by MERS-coronavirus (CoV) is a lower respiratory tract disease characterized by a high mortality rate. MERS-CoV spread from Saudi Arabia to other countries, including South Korea. Dysfunction of the human leukocyte antigen (HLA) system has many effects due to genetic complexity and its role in the adaptive immune response. We investigated the association of HLA class I and II alleles with MERS-CoV in 32 patients with MERS. Methods: HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1 were genotyped by polymerase chain reaction sequence-based typing. Results: HLA-DQB1*03:02 are significantly associated with moderate/mild cases of MERS-CoV. Other alleles are no statistical significance. Conclusions: Treatment strategies based on current research on the HLA gene and MERS-CoV will provide potential therapeutic targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据